 |
|
Altered Mental Status in Patients With Cancer
Rogerio Tuma, MD;
Lisa M. DeAngelis, MD
Arch Neurol. 2000;57:1727-1731.
Objective To identify the causes of an altered mental status in a cancer population.
Methods We studied 140 confused patients with cancer (100 prospectively and 40 retrospectively) between January 1, 1991, and June 30, 1992, to determine clinical findings, causes, and outcome.
Results All patients had non–central nervous system cancers. The most common primary cancer types were lung (20%), gastrointestinal tract (18%), leukemia and lymphoma (17%), and breast (11%). Median patient age was 73 years, and 49% were men. Disseminated systemic metastases were present in 50% of patients; 34% were confused at hospital admission and 66% developed confusion during hospitalization. Symptoms included lethargy or coma in 61% of patients, agitation in 44%, disorientation in 83%, lateralizing signs in 41%, delusions or hallucinations in 28%, and seizures in 9%. A single cause of the altered mental status was found in 33% of patients, whereas 67% had multiple causes. Drugs, especially opioids, were associated with altered mental status in 64% of patients, metabolic abnormalities in 53%, infection in 46%, and recent surgery in 32%. A structural brain lesion was the sole cause of encephalopathy in 15% of patients. Although delirium improved in 67% of patients, it was a poor prognostic factor for overall outcome. Thirty-day mortality was 25%, and 44% of patients died within 6 months, usually from progression of the underlying cancer. Prolonged delirium suggested infection or coagulopathy. Younger patients and those with hypoxemia or kidney or liver dysfunction were more likely to die (P<.05).
Conclusion Patients with cancer usually have multiple causes of delirium, many of which are treatable, with rapid improvement in their cognitive status.
From the Departments of Neurology, R. Adma Jafet, Sao Paulo, Brazil (Dr Tuma), and Memorial Sloan-Kettering Cancer Center, New York, NY (Dr DeAngelis).
RELATED ARTICLE
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2000;57(12):1794-1795.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Prostate cancer: palliative care and pain relief
Thompson et al.
Br Med Bull 2007;83:341-354.
ABSTRACT
| FULL TEXT
Impact of Delirium on Cognition, Distress, and Health-Related Quality of Life After Hematopoietic Stem-Cell Transplantation
Fann et al.
JCO 2007;25:1223-1231.
ABSTRACT
| FULL TEXT
Psychoactive Medications and Risk of Delirium in Hospitalized Cancer Patients
Gaudreau et al.
JCO 2005;23:6712-6718.
ABSTRACT
| FULL TEXT
Association Between Psychoactive Medications and Delirium in Hospitalized Patients: A Critical Review
Gaudreau et al.
Psychosomatics 2005;46:302-316.
ABSTRACT
| FULL TEXT
Methods for assessment of cognitive failure and delirium in palliative care patients: implications for practice and research
Hjermstad et al.
Palliat Med 2004;18:494-506.
ABSTRACT
Delirium in advanced cancer patients
Centeno et al.
Palliat Med 2004;18:184-194.
ABSTRACT
Nonconvulsive Status Epilepticus in Patients With Cancer: Imaging Abnormalities
Hormigo et al.
Arch Neurol 2004;61:362-365.
ABSTRACT
| FULL TEXT
Assessment of delirium in advanced cancer: The use of the bedside confusion scale
Sarhill et al.
AM J HOSP PALLIAT CARE 2001;18:335-341.
ABSTRACT
Altered Mental State and Nonconvulsive Status Epilepticus in Patients With Cancer
Cocito et al.
Arch Neurol 2001;58:1310-1310.
FULL TEXT
|
